— Know what they know.
Not Investment Advice

CRMD NASDAQ

CorMedix Inc.
1W: +1.6% 1M: +7.6% 3M: +14.7% YTD: -33.7% 1Y: -37.1% 3Y: +80.7% 5Y: +33.2%
$7.98
-0.08 (-0.99%)
 
Weekly Expected Move ±6.6%
$7 $7 $8 $8 $9
NASDAQ · Healthcare · Biotechnology · Alpha Radar Buy · Power 62 · $626.0M mcap · 72M float · 1.88% daily turnover · Short 58% of daily vol

Balance Sheet Trends

Total Assets
$826M +595.1% ▲
5Y CAGR: +75.7%
Total Liabilities
$421M +1130.9% ▲
5Y CAGR: +141.9%
Shareholders Equity
$405M +378.8% ▲
5Y CAGR: +55.7%
Cash & Investments
$150M +189.3% ▲
5Y CAGR: +26.4%
Total Debt
$149M +28702.8% ▲
5Y CAGR: +170.3%
Net Debt
$3M +107.7% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$53M$43M$44M$41M$146M
Short-Term Investments$12M$16M$32M$11M$4M
Cash & ST Investments$65M$59M$76M$52M$150M
Net Receivables$45K$0$0$52M$171M
Inventory$3K$0$2M$8M$30M
Other Current Assets$902K-$91K$960K$3M$0
Total Current Assets$66M$60M$79M$115M$350M
Property, Plant & Equip.$2M$2M$3M$2M$10M
Goodwill & Intangibles$0$0$0$2M$409M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$102K$102K$103K$105K-$10M
Total Non-Current Assets$2M$2M$3M$4M$425M
Total Assets$69M$62M$82M$119M$826M
— Liabilities —
Accounts Payable$2M$2M$4M$2M$8M
Short-Term Debt$0$0$0$0$0
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$0$0$0$0$152M
Total Current Liabilities$5M$6M$11M$34M$174M
Long-Term Debt$0$0$0$0$145M
Other Non-Current Liab.$0$0$0$0$99M
Total Non-Current Liabilities$802K$668K$517K$349K$247M
Total Liabilities$6M$7M$12M$34M$421M
— Equity —
Common Stock$38K$43K$55K$64K$79K
Retained Earnings-$246M-$275M-$322M-$340M-$177M
Accumulated OCI$87K$83K$94K$91K$3K
Total Stockholders Equity$63M$55M$70M$85M$405M
Total Liabilities & Equity$69M$62M$82M$119M$826M
— Key Metrics —
Total Debt$924K$802K$668K$517K$149M
Net Debt-$52M-$43M-$43M-$40M$3M
Total Investments$12M$16M$32M$11M$4M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms